Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
Arbutus Biopharma (ABUS) - Total debt
Total debt on the balance sheet as of December 2023 : $1.76 M
According to Arbutus Biopharma 's latest financial reports the company's total debt is $1.76 M. A company’s total debt is the sum of all current and non-current debts.
Arbutus Biopharma - Total debt on balance sheet (from 2007 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.76 M | -19.16% |
| 2022-12-31 | $2.18 M | -16.34% |
| 2021-12-31 | $2.61 M | -12.37% |
| 2020-12-31 | $2.98 M | -11.17% |
| 2019-12-31 | $3.35 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $12 M | 0% |
| 2016-12-31 | $12 M | |
| 2007-12-31 | $0.07 M | -48.38% |
| 2006-12-31 | $0.14 M | 9.6% |
| 2005-12-31 | $0.13 M | -92.39% |
| 2004-12-31 | $1.77 M | 45.16% |
| 2003-12-31 | $1.22 M | 303.9% |
| 2002-12-31 | $0.3 M | -14.81% |
| 2001-12-31 | $0.35 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.8 M | -54.47% | Bahamas |
 NRC Health
NRC | $36.68 M | 1,974.89% | 🇺🇸 USA |